BillionToOne Inc (BLLN)

Currency in USD
69.55
-1.89(-2.65%)
Closed·
69.550.00(0.00%)
·
BLLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
67.7072.34
52 wk Range
61.96138.70
Key Statistics
Prev. Close
71.44
Open
70.01
Day's Range
67.7-72.34
52 wk Range
61.96-138.7
Volume
302.5K
Average Volume (3m)
268.02K
1-Year Change
-
Book Value / Share
10.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
116.71
Upside
+67.81%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

BillionToOne Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

BillionToOne Inc Earnings Call Summary for Q4/2025

  • Q4 revenue surged 113% YoY to $96.1M, exceeding guidance of $84-90M; EPS of $0.11 met expectations vs. $1.13 loss in Q4 2024.
  • Net income turned positive at $4.4M with gross margin improving to 71.4% from 57%; operating income reached $10.3M vs. $11.7M loss prior year.
  • Stock declined 3.32% to $83.14 in after-hours despite strong results; company maintains $496M cash position with $50M term debt.
  • UNITY prenatal platform expanded capabilities; Northstar oncology portfolio drove higher test volumes and average selling prices.
  • 2026 guidance projects EPS of $0.46 and revenue of $395.3M; plans include sales force expansion and tumor-naive MRD test launch by year-end.
Last Updated: 04/03/2026, 23:08
Read Full Transcript

Compare BLLN to Peers and Sector

Metrics to compare
BLLN
Peers
Sector
Relationship
P/E Ratio
1,095.2x−2.8x−0.4x
PEG Ratio
10.590.000.00
Price/Book
6.7x1.0x2.6x
Price / LTM Sales
10.5x1.7x3.1x
Upside (Analyst Target)
72.5%197.0%56.0%
Fair Value Upside
Unlock26.5%9.0%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 116.71
(+67.81% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy130.00+86.92%-Maintain16/03/2026
BTIG
Buy140.00+101.29%160.00Maintain05/03/2026
Wells Fargo
Hold90.00+29.40%110.00Maintain05/03/2026
Guggenheim
Buy120.00+72.54%-New Coverage06/01/2026
JPMorgan
Buy145.00+108.48%150.00Maintain10/12/2025

Earnings

Latest Release
04/03/2026
EPS / Forecast
0.11 / --
Revenue / Forecast
96.1M / --
EPS Revisions
Last 90 days

People Also Watch

39.92
RAL
-2.87%
13.64
VIA
-4.08%
3.68
LAW
-8.91%
12.88
ACNT
+0.31%
72.20
IOSP
-0.23%

FAQ

What Is the BillionToOne (BLLN) Share Price Today?

The BillionToOne stock price today is 69.55 USD.

What Stock Exchange Does BillionToOne (BLLN) Trade On?

BillionToOne is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for BillionToOne?

The stock symbol (also called a 'ticker') for BillionToOne is "BLLN."

What Is the Current BillionToOne Market Cap?

As of today, BillionToOne market cap is 3.20B USD.

What Is BillionToOne's (BLLN) Earnings Per Share (TTM)?

The BillionToOne EPS is currently 0.14 (Trailing Twelve Months).

When Is the Next BillionToOne Earnings Date?

BillionToOne's next earnings report will be released on 03/06/2026.

Is BLLN a Buy or Sell From a Technical Analyst Perspective?

Based on today's BillionToOne moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BillionToOne Stock Split?

BillionToOne has split 0 times. (See the BLLN stock split history page for full effective split date and price information.)

How Many Employees Does BillionToOne Have?

BillionToOne has 713 employees.

What is the current trading status of BillionToOne (BLLN)?

As of 29/03/2026, BillionToOne (BLLN) is trading at a price of 69.55 USD, with a previous close of 71.44 USD. The stock has fluctuated within a day range of 67.70 USD to 72.34 USD, while its 52-week range spans from 61.96 USD to 138.70 USD.

What Is BillionToOne (BLLN) Price Target According to Analysts?

The average 12-month price target for BillionToOne is 116.71 USD, with a high estimate of 145 USD and a low estimate of 90 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +67.81% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.